CAS: 553-53-7; (3-Pyridylcarbonyl)Hydrazine

化学文摘社编号553-53-7,是尼可丁酸的氢氮衍生物,其特征是白色晶状和水和有机溶剂中中中溶性.该化合物主要因其作为抗结核剂的作用而得到承认,该物质通常用于治疗肺结核,因为其能够抑制细菌细胞壁中弥散酸合成.尼可丁酸氢氮化物展示一系列生物活动,包括潜在的反炎和抗氧化特性.其分子结构具有氢氮化物功能组,有助于其再活动性和生物相互作用.该化合物通常在制药环境下进行,其安全特征受到很好研究,尽管在治疗过程中可能具有需要监测的副作用.

结构式图片

相似化合物

808127-97-1 197079-25-7 112193-41-6

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号93-60-7 烟酸甲酯 | CAS号614-18-6 烟酸乙酯 | CAS号59-67-6 烟酸 | CAS号98-92-0 烟酰胺 | CAS号10400-19-8 烟酰氯 | CAS号110925-43-4 N'-(1-((2S,4S)-... | CAS号1094260-38-4 6-chloro-3-pyri... | CAS号35607-27-3 5-(吡啶-3-基)-4H-1... | CAS号500-22-1 吡啶-3-甲醛 | CAS号141079-04-1 3-[5-[(4-methyl... | CAS号141079-09-6 3-[5-[(4-chloro... | CAS号3690-46-8 5-(3-吡啶基)-1,3,4... | CAS号51362-49-3 2-苯氧基吡啶-3-羰酰氯 | CAS号21398-08-3 3-(5-phenyl-1,3... | CAS号18960-15-1 3-Pyridinecarbo... | CAS号59-67-6 烟酸

合成工艺路线路线简述

    烟酰胺置于一水合肼体系中,用 乙醇 作为反应溶剂,化学反应 6.0H,以85%的收率获得产物3-吡啶甲酰肼
    参考文献:1-丙二酰基-1,4-二氢吡啶作为一种新型载体,可以特异性地将药物输送到大脑
    标题:1-丙二酰基-1,4-二氢吡啶作为一种新型载体,可以特异性地将药物输送到大脑
    摘要:合成了一组1-丙二酰基-1,4-二氢吡啶衍生物,将其作为新型载体系统用于位点特异性和持续向大脑的药物递送.由于存在靠近二氢吡啶的氮的羰基,预期这类载体对空气氧化是稳定的.这些载体体系连接到一组不同的醛上,得到新颖的季吡啶鎓衍生物9A-E,11A-D,13和18A-B.用连二亚硫酸钠还原制备的季吡啶鎓衍生物可得到一组新的1-丙二酰基-1,4-二氢吡啶化学传递系统(cdss)10A-E,12A-D,14和19A-B.对合成的1-丙二酰基-1,4-二氢吡啶cds进行了各种化学和生物学研究,以评估其穿越血脑屏障并被生物氧化为相应的季衍生物的能力.体外氧化研究表明,大多数1-丙二酰基-1,4-二氢吡啶cds可以适当的速率被氧化成其相应的季衍生物.体内研究表明,化合物10C和14能够以可检测的浓度穿过血脑屏障.此外,吡啶鎓季铵中间体9A,图9C,13,18A和其相应的二氢衍生物
    DOI:10.1016/j.Bmc.2008.12.051

    海关参考信息

    专利信息


    专利号:US-5424432-A
    优先权日:1994-05-26
    标题:Process for the preparation of imidazolutidine
    发明人:FREDENBURGH LAURA E; LARSEN ROBERT D; LIU JI; REAMER ROBERT A; SENANAYAKE CHRIS H; VERHOEVEN THOMAS R
    权利人:MERCK & CO INC
    摘要:This invention relates to a method for the preparation of a compound of formula I: I a key intermediate in the synthesis of a series of Angiotensin II receptor antagonists. The invention also relates to a selective reagent for conducting the Hofmann rearrangement, particularly in the formation of a pyridinoimidazolone, which is a percursor to the formation of an imidazopyfidine of formula I. This invention also relates to a method for the preparation of imidazolutidine, a key intermediate in the synthesis of 3-(2'-(N-benzoyl)sulfonamidobiphen-4-yl)-methyl-5,7 -dimethyl-2-ethyl-3H-imidazo[4,5-b]pyridine, using pyridinoimidazolone, an unreactive urea.

    专利号:WO-2022238921-A1
    优先权日:2021-05-14
    标题 :In-situ synthesis of 3-substituted pyridinium compounds
    发明人:GUPTA RAMESHCHANDRA; SRIVASTAVA SANJAY; PATEL MANISH
    权利人:TORRENT PHARMACEUTICALS LTD
    摘要:Present invention relates to an in-situ and improved process for the preparation of 3-{[2-(methylsulfonyl)hydrazinyl]carbonyl}- 1-[2-oxo-2- (thiophen-2-yl)ethyl]pyridinium salts or salt-cocrystal.

    专利号:US-4894380-A
    优先权日:1987-04-03
    标题:2-mercapto-5-pyridyl-1,3,4-oxadiazoles and 2-mercapto-5-pyridyl-1,3,4-thiadiazoles of the formula I
    发明人:NYFELER ROBERT; ECKHARDT WOLFGANG; BERIGER ERNST; KRISTIANSEN ODD
    权利人:CIBA GEIGY CORP
    摘要:The invention relates to 2-mercapto-5-pyridyl-1,3,4-oxadiazoles and 2-mercapto-5-pyridyl-1,3,4-thiadiazoles of the formula I (I) wherein X is oxygen or sulfur, R' is C1-C3alkyl which is substituted by bromine, fluorine, C1-C3alkoxy or cyano; unsubstituted or halogen-substituted C3-C7alkenyl; unsubstituted or halogen-substituted C4-C7alkynyl, R is C1-C3alkyl, unsubstituted C1-C3alkoxy or C1-C3alkoxy which is substituted by halogen or C1-C3alkoxy; unsubstituted or halogen-substituted C3-C7alkenyl; C3-C7alkynyl, C1-C3alkylthio, halogen, cyano, hydroxy, amino or amino which is substituted by one or two C1-C3alkyl groups; or is aminocarbonyl; and n is 0, 1, 2, 3 or 4, to the preparation of the compounds of formula I and to novel intermediates for the synthesis of these compounds. The compounds of formula I have nematicidal properties. The invention further relates to nematicidal compositions which contain at least one compound of formula I as active component, and to methods of using said compounds and of the compositions containing them for controlling nematodes.

    专利号:US-8895747-B2
    优先权日:2009-07-27
    标 题 :Method and substances for preparation of N-substituted pyridinium compounds
    发明人:HEINDL DIETER; MAERZ HERIBERT; SCHMIDT AXEL
    权利人:HEINDL DIETER; MAERZ HERIBERT; SCHMIDT AXEL; ROCHE DIAGNOSTICS OPERATIONS
    摘要:Methods for the synthesis of N-substituted pyridinium compounds by using an N-heteroaryl substituted pyridinium salt (Zincke salt) and reacting it with a nucleophilic amine are provided. Novel purine-substituted pyridyl compounds, which may be useful reagents in the above reaction, are also disclosed.

    专利号:TW-202311253-A
    优先权日:2021-05-14
    标 题 :In-situ synthesis of 3-substituted pyridinium compounds

    专利号:US-2024335420-A1
    优先权日:2021-08-02
    标题:N-acylhydrazone compounds capable of inhibiting nav 1.7 and/or nav 1.8, processes for the preparation thereof, compositions, uses, methods for treatment using same and kits
    发明人:BARREIRO GABRIELA; SANT'ANA DANILO PEREIRA DE; GAMBA LUIS EDUARDO REINA; FRAGA CARLOS ALBERTO MANSSOUR; BARREIRO ELIEZER JESUS DE LACERDA; LIMA LÃ?DIA MOREIRA
    权利人:EUROFARMA LABORATORIOS S A; UNIV FEDERAL DO RIO DE JANEIRO UFRJ
    摘要:N-Acylhydrazone compounds that are Nav 1.7 and/or Nav 1.8 inhibitors, including N-acylhydrazone compounds of Formula (I), wherein substituents R1 to R4 are independently selected from the groups defined in the specification, as well as to the processes for the preparation thereof, compositions comprising at least one of these compounds, uses, treatment methods for treating or preventing pain-related pathologies, and kits, useful in the fields of medicinal chemistry, organic synthesis, as well as in the treatment of pain-related disorders.
    怀化市冰峰化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bingfengchem.com
    企业联系电话:0745-2866851/17307457092👤
    📞怀化市冰峰化工有限公司 ⚠️参考联系方式
    联系人:销售经理
    电话:0745-2866851/17307457092
    手机:17307457092
    传真:QQ:406037272
    邮箱:sales@bingfengchem.com
    通信地址: 怀化市洪江区岩门工业园
    邮编: 418000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:怀化市洪江区岩门工业园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    常州市宣明医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://xuanmingchem.com
    企业联系电话:0519-85525329👤
    📞常州市宣明医药科技有限公司 ⚠️参考联系方式
    联系人:刘明;许雯
    电话:0519-85525329
    手机:15951231113;13646117943
    传真:0519-85190960
    邮箱:sales@xuanmingchem.com
    通信地址: 江苏省常州市新北区汉江路120号
    邮编: 213000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市新北区汉江路120号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Kruszynski R. A Structural And Theoretical Study Of Intermolecular Interactions In Nicotinohydrazide Dihydrochloride. Acta Crystallogr C. 2011 Feb;67(Pt 2):O52-6.
    [参考文献]: Alireza Moradi, Et Al. Design And Synthesis Of 2-Phenoxynicotinic Acid Hydrazides As Anti-Inflammatory And Analgesic Agents. Arch Pharm (Weinheim). 2010 Sep;343(9):509-18.
    [参考文献]: B J Van Der Walt, Et Al. Different Oxidative Pathways Of Isonicotinic Acid Hydrazide And Its Meta-Isomer, Nicotinic Acid Hydrazide. Int J Biochem. 1994 Sep;26(9):1081-93.
    [参考文献]: C C K Hui, Et Al. T Cell-Mediated Induction Of Thymic Stromal Lymphopoietin In Differentiated Human Primary Bronchial Epithelial Cells. Clin Exp Allergy. 2014 Jul;44(7):953-64.
    [参考文献]: H A Shoeb, Et Al. Peroxidase-Mediated Oxidation Of Isoniazid. Antimicrob Agents Chemother. 1985 Mar;27(3):399-403.

    合成参考文献


    参考文献:10.1107/s1600536811014140
    摘要:Wu JM, Guo W, Li CP. 3,4-Bis(2-pyrid-yl)-5-(3-pyrid-yl)-4H-1,2,4-triazole. Acta Crystallogr Sect E Struct Rep Online. 2011 May 01;67(Pt 5):o1189.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知